In focus · trending topic

specialty pharma

3 stories · following the connections

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

By Nasdaq OMXJan 10, 2018, 1:02 PM UTC

Elite Pharmaceuticals Files ANDA for Pain Product

By Nasdaq OMXApr 4, 2017, 4:06 PM UTC

Agile Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference

By Nasdaq OMXDec 22, 2016, 12:30 PM UTC